139 related articles for article (PubMed ID: 30525252)
1. Rhodotorula infection in haematological patient: Risk factors and outcome.
Potenza L; Chitasombat MN; Klimko N; Bettelli F; Dragonetti G; Del Principe MI; Nucci M; Busca A; Fracchiolla N; Sciumè M; Spolzino A; Delia M; Mancini V; Nadali GP; Dargenio M; Shadrivova O; Bacchelli F; Aversa F; Sanguinetti M; Luppi M; Kontoyiannis DP; Pagano L
Mycoses; 2019 Mar; 62(3):223-229. PubMed ID: 30525252
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and outcome of Rhodotorula infection in haematological patients.
García-Suárez J; Gómez-Herruz P; Cuadros JA; Burgaleta C
Mycoses; 2011 Jul; 54(4):318-24. PubMed ID: 20337934
[TBL] [Abstract][Full Text] [Related]
3. Rhodotorula species infections in humans: A systematic review.
Ioannou P; Vamvoukaki R; Samonis G
Mycoses; 2019 Feb; 62(2):90-100. PubMed ID: 30267601
[TBL] [Abstract][Full Text] [Related]
4. Mixed treatment comparison of prophylaxis against invasive fungal infections in neutropenic patients receiving therapy for haematological malignancies: a systematic review.
Pechlivanoglou P; Le HH; Daenen S; Snowden JA; Postma MJ
J Antimicrob Chemother; 2014 Jan; 69(1):1-11. PubMed ID: 23975736
[TBL] [Abstract][Full Text] [Related]
5. Multicentre surveillance study on feasibility, safety and efficacy of antifungal combination therapy for proven or probable invasive fungal diseases in haematological patients: the SEIFEM real-life combo study.
Candoni A; Caira M; Cesaro S; Busca A; Giacchino M; Fanci R; Delia M; Nosari A; Bonini A; Cattaneo C; Melillo L; Caramatti C; Milone G; Scime' R; Picardi M; Fanin R; Pagano L;
Mycoses; 2014 Jun; 57(6):342-50. PubMed ID: 24373120
[TBL] [Abstract][Full Text] [Related]
6. Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009.
Campo M; Lewis RE; Kontoyiannis DP
J Infect; 2010 May; 60(5):331-7. PubMed ID: 20138081
[TBL] [Abstract][Full Text] [Related]
7. Hema e-Chart registry of invasive fungal infections in haematological patients: improved outcome in recent years in mould infections.
Nosari AM; Caira M; Pioltelli ML; Fanci R; Bonini A; Cattaneo C; Castagnola C; Capalbo SF; De Fabritiis P; Mettivier V; Morselli M; Pastore D; Aversa F; Rossi G; Pagano L;
Clin Microbiol Infect; 2013 Aug; 19(8):757-62. PubMed ID: 23279327
[TBL] [Abstract][Full Text] [Related]
8. [A Rare Yeast: Cases of Rhodotorula mucilaginosa Infection Followed Up in a Tertiary University Hospital].
Ayaz ÇM; Gülmez D; Arıkan Akdağlı S; Uzun Ö
Mikrobiyol Bul; 2021 Jan; 55(1):91-98. PubMed ID: 33590984
[TBL] [Abstract][Full Text] [Related]
9. Fungemia due to Rhodotorula mucilaginosa after allogeneic hematopoietic stem cell transplantation.
Mori T; Nakamura Y; Kato J; Sugita K; Murata M; Kamei K; Okamoto S
Transpl Infect Dis; 2012 Feb; 14(1):91-4. PubMed ID: 21535337
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and outcomes of patients with invasive mould infections: a retrospective observational study from a single centre (2005-2009).
Klingspor L; Saaedi B; Ljungman P; Szakos A
Mycoses; 2015 Aug; 58(8):470-7. PubMed ID: 26152371
[TBL] [Abstract][Full Text] [Related]
11. Efficacy, safety, and breakthrough infections associated with standard long-term posaconazole antifungal prophylaxis in allogeneic stem cell transplantation recipients.
Winston DJ; Bartoni K; Territo MC; Schiller GJ
Biol Blood Marrow Transplant; 2011 Apr; 17(4):507-15. PubMed ID: 20460163
[TBL] [Abstract][Full Text] [Related]
12. Isolation of Rhodotorula mucilaginosa from blood cultures in a tertiary care hospital.
Falces-Romero I; Cendejas-Bueno E; Romero-Gómez MP; García-Rodríguez J
Mycoses; 2018 Jan; 61(1):35-39. PubMed ID: 28922488
[TBL] [Abstract][Full Text] [Related]
13. Treatment of invasive fungal infections in high risk hematological patients. The outcome with liposomal amphotericin B is not negatively affected by prior administration of mold-active azoles.
De la Serna J; Jarque I; López-Jiménez J; Fernández-Navarro JM; Gómez V; Jurado M; Pascual A; Serrano J; Romero M; Vallejo C
Rev Esp Quimioter; 2013 Mar; 26(1):64-9. PubMed ID: 23546466
[TBL] [Abstract][Full Text] [Related]
14. Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies.
Maertens J
Eur J Haematol; 2007 Apr; 78(4):275-82. PubMed ID: 17241370
[TBL] [Abstract][Full Text] [Related]
15. Effects of liposomal amphotericin B versus an amphotericin B lipid complex on liver histopathology in patients with hematologic malignancies and invasive fungal infections: a retrospective, nonrandomized autopsy study.
Chamilos G; Luna M; Lewis RE; Chemaly R; Raad II; Kontoyiannis DP
Clin Ther; 2007 Sep; 29(9):1980-6. PubMed ID: 18035197
[TBL] [Abstract][Full Text] [Related]
16. Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis.
Montesinos P; Rodríguez-Veiga R; Boluda B; Martínez-Cuadrón D; Cano I; Lancharro A; Sanz J; Arilla MJ; López-Chuliá F; Navarro I; Lorenzo I; Salavert M; Pemán J; Calvillo P; Martínez J; Carpio N; Jarque I; Sanz GF; Sanz MA
Bone Marrow Transplant; 2015 Nov; 50(11):1465-72. PubMed ID: 26281032
[TBL] [Abstract][Full Text] [Related]
17. Clinical and microbiological characteristics of Rhodotorula mucilaginosa infections in a tertiary-care facility.
Capoor MR; Aggarwal S; Raghvan C; Gupta DK; Jain AK; Chaudhary R
Indian J Med Microbiol; 2014; 32(3):304-9. PubMed ID: 25008826
[TBL] [Abstract][Full Text] [Related]
18. Rhodotorula fungemia of an intensive care unit patient and review of published cases.
Spiliopoulou A; Anastassiou ED; Christofidou M
Mycopathologia; 2012 Oct; 174(4):301-9. PubMed ID: 22576941
[TBL] [Abstract][Full Text] [Related]
19. [Rhodotorula glutinis sepsis. A case report].
Pulvirenti F; Pasqua P; Falzone E; Maffeo F; Gugliara C; Guarneri L
Infez Med; 2010 Jun; 18(2):124-6. PubMed ID: 20610937
[TBL] [Abstract][Full Text] [Related]
20. Virulence and antifungal therapy of murine disseminated infection by Rhodotorula mucilaginosa.
Thomson P; López-Fernández L; Guarro J; Capilla J
Diagn Microbiol Infect Dis; 2017 Sep; 89(1):47-51. PubMed ID: 28669678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
